D. J. St. Germain »

Brainstorm Cell Therapeutics shares owned by D. J. St. Germain

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by D. J. St. Germain from 13F filings

Historical chart of D. J. St. Germain investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by D. J. St. Germain consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by D. J. St. Germain

Quarter filed Position value Share count Share price at filing
2025-09-30 $23 33 0.70
2025-06-30 $36 33 1.12
2025-03-31 $41 33 1.27
2024-12-31 $74 33 2.27
2024-09-30 $115 500 0.23

More positions owned by D. J. St. Germain

Jpmorgan U.s. Quality Factor Etf Etf (JQUA)
Apple Stock (AAPL)
Alphabet Inc Cl A Stock (GOOGL)
Spdr Portfolio S&p 500 Etf Etf (SPLG)
Meta Platforms Inc Cl A Stock (META)
Spdr Portfolio Corporate Bond Etf Etf (SPBO)
Jpmorgan Chase & Co Stock (JPM)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Microsoft Corp Stock (MSFT)
Netflix Stock (NFLX)
Nvidia Corporation Stock (NVDA)
Janus Henderson Aaa Clo Etf Etf (JAAA)
Procter And Gamble Stock (PG)
Ishares Mbs Etf Etf (MBB)
Amazon.com Stock (AMZN)

View all positions for D. J. St. Germain

Top funds holding Brainstorm Cell Therapeutics

Morgan Stanley
Advisor Group Holdings
Bangor Savings Bank
VSM Wealth Advisory
Steward Partners Investment Advisory
D. J. St. Germain

View all funds holding Brainstorm Cell Therapeutics